New American Cancer Society data show cancer survival rates hit 70%, but lung cancer remains the deadliest, and access to...
Survival
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have demonstrated that doxycycline, a...
TORONTO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- In a stunning turnaround, the once universally grim prognosis for lung cancer is...
Neuvivo’s investigational therapy NP001 (sodium chlorite), designed to dampen inflammation and restore immune system balance, extended survival in people with...
A regional primary care, nonphysician-based program for chronic obstructive pulmonary disease (COPD) was associated with improved longer-term survival, a propensity-matched...
